Trial Profile
Phase 3 : Tacrolimus Ointment Interest (PROTOPIC) in the Maintenance Treatment of Severe Seborrheic Dermatitis on Adult Face
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Oct 2020
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary) ; Ciclopirox
- Indications Seborrhoeic dermatitis
- Focus Therapeutic Use
- 30 Sep 2020 Primary endpoint (Disease-Free Duration (DFD)) has been met as per results published in the Journal of the American Academy of Dermatology
- 30 Sep 2020 Results published in the Journal of the American Academy of Dermatology
- 25 May 2018 Status changed from recruiting to completed.